Print the page
Increase font size
The Consent Nobody Gave

Posted July 27, 2026

Sean Ring

By Sean Ring

The Consent Nobody Gave

On Tuesday afternoon, a small committee decided what the House would not be allowed to discuss.

Thomas Massie and Ro Khanna had written an amendment together. One Republican, one Democrat. It would have pulled a single section out of the defense bill.

The Rules Committee didn't vote it down. It just left it off the list.

Anna Paulina Luna filed her own version. Same result.

So on Wednesday, the House passed a $1.15 trillion defense bill, 216 to 212. The section stayed in. And not one member ever had to say yes or no to it on the record.

Watch how that worked. You'll see it again.

The Section Nobody Voted On

Section 219 sets up a joint defense technology program with Israel. It used to be numbered 224. It puts one Pentagon official in charge of the whole effort.

The list of covered fields is long. Counter-drone systems. Missile defense. Artificial intelligence. Quantum. Autonomous systems. Cyber. Electronic warfare. Biotech. It also covers joint production, shared supply chains, and folding Israeli or jointly built technology into American military programs.

Now let's be precise, because precision is the whole game here.

Committee chairman Mike Rogers says the section doesn’t merge command structures. It doesn’t put American troops under foreign orders. It doesn’t hand over control of our operations. He's right on all three counts. The two countries have built weapons together for decades. Iron Dome. Arrow. David's Sling. Much of this work already exists.

If you hear somebody say Congress merged the two armies on Wednesday, they've overshot. And the overshoot is exactly what lets the whole argument get waved away.

The quieter provision is the one to watch.

A Law About What A Future President May Decide

Section 622 expands intelligence sharing and limits the restrictions on it. The Senate's version goes further. It would stop a president from scaling back intelligence cooperation over human rights concerns unless he notifies Congress and names American security as his reason.

To be sure, that’s a statute telling a future commander-in-chief how he may use his own judgment.

There's one more detail worth your time. A letter from Bibi himself in June described the shift from American aid toward joint development and production as "my plan."

Take that for what it is: a foreign leader, claiming authorship of an American bill, in writing.

The Same Day, A Different Deal

While that was happening, Energy Secretary Chris Wright signed a nuclear cooperation deal with Saudi Arabia's energy minister.

It runs 30 years. It's worth tens of billions. American firms get first call on supplying the reactors and the fuel.

What's missing is the language experts call the gold standard. That's the clause barring a partner from enriching uranium or reprocessing spent fuel. It isn't in there. Reporting indicates the safeguards would be run by the two governments rather than by the international agency that usually does the job.

Congress gets 90 days to look at it. To stop it, both chambers have to pass a resolution of disapproval.

Notice the default mode here: Silence is a tacit approval.

And in fairness, there's a real case for the deal. The Saudis are going to build reactors either way. Better American vendors, American fuel, and American engineers on site than Russian or Chinese ones with nobody watching. That argument deserves a hearing, and it rarely gets one.

What The Two Have In Common

The partner country isn’t the problem. It’s how long future generations are wedded to the deal their grandparents made.

One deal runs three decades. The other writes cooperation into permanent law instead of policy. Policy is what the next administration can change on a Tuesday. But it can’t change the law.

The Founding Fathers thought hard about this. They decided two-thirds of the Senate had to approve a treaty, because deals like this outlive the men who agree to them. A high bar was the price of binding future generations.

Neither of these things faced that bar.

One rode in on a bill nobody was allowed to amend. The other takes effect unless both chambers stand up and stop it.

That's the lock.

Nobody Had To Be Corrupt

You don’t need a corrupt villain for this to happen.

Every player did the rational thing. Committee leaders wanted a clean bill. Leadership wanted the votes. Members wanted to avoid a roll call that could be clipped and mailed to their district in October. The Rules Committee gave all of them what they wanted by giving them nothing to vote on.

Bad outcomes don't require bad men. They just need a process where dodging a vote is easier than taking one.

Sadly, the path of least resistance is one politicians usually follow.

It Isn't Finished

None of this is law yet. The Senate hasn't passed its own defense bill. A procedural vote there failed 50 to 46 on July 14. Section 219 is the House position, nothing more. Both chambers still have to agree on identical text. The section can be changed, watered down, or dropped in those talks.

The Saudi agreement has its 90 days on the clock right now.

So there are three things worth watching, and you now know to watch them.

One: whether Section 219 survives the House and Senate negotiations.

Two: whether Senate leaders find 60 votes for their version.

Three: whether anyone files a disapproval resolution before the nuclear clock runs out.

Wrap Up

The story will get reported to you as a fight about one foreign country. It isn't.

It's a fight about how long a deal lasts, and how few people have to sign it.

The Market Nobody Ordered

The Market Nobody Ordered

Posted July 24, 2026

By Sean Ring

Before Wall Street became the world’s financial capital, it was a crowded coffee house where merchants traded news, ships, property, and stocks. Sean Ring visits the corner where America’s markets emerged without a blueprint—and finds a darker example of what happened when government did the planning.
The Magic Pill’s Real Trick

The Magic Pill’s Real Trick

Posted July 23, 2026

By Ray Blanco

GLP-1 drugs were built to shrink waistlines. Now human trials suggest they may also reduce inflammation, protect the heart, and slow the body’s biological clock. Ray Blanco reveals why the biggest medical story of the decade is no longer merely about weight loss.
Dead Cat Bounces

Dead Cat Bounces

Posted July 22, 2026

By Sean Ring

Silver’s sudden rally has the bulls declaring victory again. But the chart, the dollar, and the industrial backdrop still point the other way. Sean Ring explains why patient investors should let the metal prove it’s alive before touching the miners.
Crude Lies

Crude Lies

Posted July 21, 2026

By Matt Badiali

Falling crude prices should mean cheaper gasoline and diesel. But destroyed refining capacity has broken that relationship. Matt Badiali reveals why fuel inflation could remain stubbornly high—and which battered sector stands to benefit.
The SPR Boomerang

The SPR Boomerang

Posted July 20, 2026

By Zach Scheidt

Releasing oil from the Strategic Petroleum Reserve helped keep crude prices under control. Refilling it could do precisely the opposite. Zach Scheidt explains why that reversal creates an unusually attractive setup for energy investors.
Silver’s Double Whammy

Silver’s Double Whammy

Posted July 17, 2026

By Sean Ring

Silver bulls got the fundamentals right and the timing painfully wrong. One Fed shift hit both of silver’s engines at once—and turned its greatest advantage into a 54% collapse.